Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.

Liangliang Li, Chongyang Wu, Ye Chai, Chi Dong, Li Zhao

Open access · goldAbstract readCase ReportsReview

In one paragraph

Review in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

1.4field-weighted citation impact, top 18% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

Chemo-free salvage treatment outperforms traditional chemotherapy in advanced lines of relapsed/refractory subcutaneous panniculitis-like T-cell lymphoma.Frontiers in immunology · 2024
Article
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor.Case reports in oncology
Article
Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome Treated with Romidepsin and Allogeneic Hematopoietic Cell Transplantation.Case reports in oncology
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Liangliang LiThe First Clinical Medical College of Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0002-0078-6280

Chongyang WuDepartment of Hematology, Lanzhou University Second Hospital, Lanzhou, China.

Ye ChaiDepartment of Hematology, Lanzhou University Second Hospital, Lanzhou, China.

Chi DongDepartment of Pathology, Lanzhou University Second Hospital, Lanzhou, China.

Li ZhaoDepartment of Central Laboratory, The First Hospital of Lanzhou University, Lanzhou, China.

Lanzhou University Second Hospital · CNFirst Hospital of Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma composed of CD8

Indexed as

AminopyridinesAntineoplastic Combined Chemotherapy ProtocolsBenzamidesCyclophosphamideDoxorubicinEtoposideFemaleHistone Deacetylase InhibitorsHumansLymphoma, T-CellMiddle AgedPanniculitisPrednisoneRemission InductionVincristineAminopyridinesBenzamidesCyclophosphamideDoxorubicinEtoposideHistone Deacetylase InhibitorsN-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamidePrednisoneVincristinechidamidehistone deacetylase inhibitorlong-term remissionsubcutaneous panniculitis-like T-Cell lymphoma

Identifiers

PMID33845613

DOI10.1177/20587384211009342

PMCPMC8059039

OpenAlexW3156651622

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.